Bleeding duodenal ulcer on aspirin and NSAIDs: eradication and antithrombotic decisions
A 52-year-old taxi driver is admitted with 12 hours of melena and light-headedness. He had a myocardial infarction 18 months ago and takes aspirin 81 mg daily. For 3 months he has also taken ibuprofen 600 mg three times daily for knee osteoarthritis, together with omeprazole 20 mg daily. Pulse is 104, blood pressure 108/66 supine, haemoglobin 7.6 g/dL, urea 58 mg/dL, creatinine normal. After two units of packed red cells, endoscopy shows a 1.2 cm ulcer in the posterior duodenal bulb with a large adherent clot and no active bleeding; adrenaline injection (1:10,000, 8 mL) plus three clips achieves hemostasis. The registrar takes two antral biopsies for rapid urease testing, which returns negative. The patient reports two previous courses of clarithromycin-based triple therapy, the last 3 years ago. He is keen to restart ibuprofen because of his knee. The hospital is in Egypt, where clarithromycin resistance is high.
1. How do you interpret the negative rapid urease test, and what eradication regimen would you prescribe?
Read the worked answer
The negative rapid urease test cannot be trusted in this patient for two reasons. First, he has been taking omeprazole, and proton pump inhibitors suppress urease activity and produce false-negative results; second, biopsies were taken from the antrum only, whereas a recent bleed and PPI use both reduce bacterial density. The correct interpretation is 'indeterminate, not negative'. A urea breath test or stool antigen test should be done, but not during the acute admission: it must be at least 4 weeks after antibiotics and 2 weeks after stopping the PPI, otherwise the result is uninterpretable.
Treatment should be given now rather than deferred, because he has a bleeding ulcer and prior eradication failures. In a high-clarithromycin-resistance region, and with two prior macrolide courses, a 14-day bismuth quadruple regimen is the rational choice: a PPI at standard or double dose, bismuth subcitrate or subsalicylate four times daily, tetracycline 500 mg four times daily, and metronidazole 400-500 mg three times daily. Adherence counselling matters as much as the prescription: bismuth darkens stools, tetracycline must be separated from dairy and antacids, and completing all 14 days is essential.
Because this is a bleeding ulcer with prior failure, culture and susceptibility testing at endoscopy, if available, would allow a tailored second-line choice, for example a levofloxacin-based quadruple regimen. Levofloxacin should not be used empirically if he has had prior quinolone exposure. Salvage options after repeated failure include rifabutin-based triple therapy, with attention to interactions.
2. Address antithrombotic and NSAID management: when to restart aspirin, and what should replace ibuprofen?
Read the worked answer
Aspirin should be restarted early, not withheld until the ulcer has healed. He has established coronary disease and an acute upper gastrointestinal bleed; withholding antiplatelet therapy increases the risk of myocardial infarction, and the evidence supports restarting aspirin as soon as hemostasis is achieved, generally within 1-3 days in patients at high cardiovascular risk. Endoscopic hemostasis was successful and he is not actively bleeding, so aspirin can restart today or tomorrow. The common error, stopping aspirin for weeks, causes more harm than good.
Ibuprofen must stop. The combination of an NSAID with low-dose aspirin multiplies gastrointestinal risk, and this patient has already bled. For his knee, first-line measures are paracetamol, topical NSAID gel, physiotherapy and weight management, all of which have minimal gastrointestinal risk. If systemic anti-inflammatory treatment is truly needed, the least harmful option is celecoxib at the lowest effective dose plus continuous PPI, having considered cardiovascular and renal risk; a traditional NSAID plus PPI is a second choice. The PPI should be continued long term, not just for 8 weeks, because he remains on aspirin with a prior ulcer.
Finally, he should be counselled explicitly that omeprazole 20 mg daily did not prevent this bleed when combined with an NSAID, and that he must not self-medicate with over-the-counter ibuprofen. Documentation of the drug reaction and a note to his cardiologist and primary care physician close the loop.
3. How and when will you confirm eradication, and what is the plan if the test is still positive?
Read the worked answer
Confirmation is mandatory in this patient because he has a bleeding ulcer, prior treatment failures, and ongoing aspirin use - all situations where a missed infection risks recurrence. The test should be a urea breath test or a stool antigen test, performed at least 4 weeks after the last antibiotic and at least 2 weeks after stopping the PPI; testing earlier, or with serology, is meaningless. If he needs continued acid suppression for symptoms, an H2 receptor antagonist can be substituted for 2 weeks before testing because it interferes less.
If the test remains positive, the next step is not simply to repeat the same regimen. Whenever possible, endoscopy with gastric biopsies for culture and susceptibility, or molecular testing for clarithromycin and levofloxacin resistance, should guide the choice. Empirically, a levofloxacin-based quadruple regimen for 14 days is a standard rescue, but only if there has been no prior quinolone exposure; otherwise rifabutin-based triple therapy or a repeat bismuth quadruple with different antibiotics is preferred. Metronidazole resistance is common, so bismuth quadruple reuse is weaker after one failure.
After successful eradication, the ulcer is considered H. pylori-negative and the risk of rebleeding falls substantially, but aspirin and PPI continue. If eradication cannot be achieved after two rescue attempts, long-term PPI maintenance is appropriate and the situation should be documented. Re-endoscopy is not routinely required for a healed duodenal ulcer, but it is warranted if symptoms persist or the ulcer was gastric.